Skip to main content
. 2006 Oct-Dec;10(4):432–438.

Table 3.

Pathologic and Follow-up Data

HALN* ON* P Value
Mean Follow-up mos (range) 31.7 (8–47) 51.0 (13–135) <0.05
Pathologic Grade (%)
    Low (I and II) 23 (60) 33 (63) 0.78
    High (III) 15 (40) 19 (37)
Pathologic Stage (%)
    Superficial (Ta+Tis+T1) 27 (71) 41 (79) 0.67
    Invasive (T2+T3+T4) 9 (29) 11 (21)
Mean Interval to Recurrence (mos) 7.7 9.1 0.55
Recurrence of TCC* (%)
    Bladder 11 (29) 18 (35) 0.32
    Contralateral ureter 1 (3) 2 (4)
    Urethra 1 (3) 0 (0)
    Metastatic 2 (6) 6 (11)
Current Disease Status*
    NED 22 (58) 23 (44) 0.78
    AWD 14 (37) 17 (33) 0.69
    DOD 1 (3) 9 (17) 0.03
    DWOD 1 (3) 3 (6) 0.51
*

HALN=hand-assisted laparoscopic nephroureterectomy; ON= open nephroureterectomy; TCC=transitional cell carcinoma; NED=no evidence of disease; AWD=alive with disease; DOD=dead of disease; DWOD=dead without disease.